This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Ozempic (Semaglutide) 1 mg/dose (4 mg/3 ml) 3 ml. The contract, valued at $10,449.36, was awarded by the Defense Logistics Agency (DLA) on May 10, 2024 and has a completion date of May 13, 2024. This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This particular award does not have a set-aside designation.
Generated 8/9/24, 9:32 AM